$480 million Fort Myers biotech firm names interim CEO

The appointment comes less than two months after the previous CEO’s resignation.

  • By Business Observer Staff
  • | 10:50 a.m. May 18, 2022
  • Charlotte–Lee–Collier
  • Share

NeoGenomics, a cancer-focused genetic testing services and oncology contract research firm, has named Lynn Tetrault, the current executive chair and principal executive officer, as board chair and interim CEO.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news
Subscribe

Already subscribed? Sign in.

Latest News

  • April 2, 2026
Sarasota Doctors Hospital names new COO
  • April 2, 2026
Babcock Ranch shopping center gets refinance
  • April 2, 2026
Report: Childhood poverty pockets remain in region amid Florida decline
  • April 2, 2026
Hillsborough to spend $70M on stormwater drainage improvements

Sponsored Content